NBI-77860

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBI-77860, covering 2015-06-11 to 2015-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia [Phase 1]

See pricing